Achieve, Disc, Revolution among winners of initial FDA national priority vouchers
Source: SeekingAlpha
2025-10-17 07:12:04 ET
More on Regeneron, Achieve Life Sciences, etc.
- Regeneron: Growth Catalysts Incoming
- Achieve Life Sciences: Promising Pipeline But High Risks Makes Me Hold For Now
- Regeneron: Strong R&D Pipeline Drives Growth Outlook
- Regeneron gets FDA nod for Libtayo for squamous cell cancer
- Regeneron says $83M acquired IPR&D charge to negatively hit Q3 income
Read the full article on Seeking Alpha
For further details see:
Achieve, Disc, Revolution among winners of initial FDA national priority vouchers
Achieve Life Sciences Inc.
NASDAQ: ACHV
ACHV Trading
0.0% G/L:
$5.37 Last:
868,968 Volume:
$5.10 Open:
ACHV Latest News
May 19, 2026 02:15:00 pm
Achieve Life Sciences Presents Safety Data from 52 Weeks of Continuous Cytisinicline Treatment
May 12, 2026 07:05:00 am
Achieve Life Sciences Strengthens Board and Commercial Leadership with Three Senior Appointments from Team Previously at Verona Pharma
May 12, 2026 07:00:00 am
Achieve Life Sciences Reports First Quarter 2026 Financial Results and Provides Business Updates
ACHV Stock Data
$234,761,887
51,636,968
N/A
28
N/A
Biotechnology & Life Sciences
Healthcare
CA
Bothell
